Skip to main content
Knowledge Base
for the National TB Elimination Program - NTEP
Main navigation
Home
About Us
Curriculum
Search Courses
Knowledge Map
Knowledge Map Summary
Page Library
Content Page Summary
Translations
Documents
Select your language
English
Hindi
Tamil
Gujarati
Marathi
Telugu
Oriya
Search
Search
Final Review
Home
Final Review
Content Status at the final stage of review before it is approved for use.
State Airborne Infection Control [AIC] Committee
H5Content
Management of Hepato-toxicity During Treatment with H Mono/Poly DR-TB Regimen
H5Content
Management of Prolonged QTcF During Treatment with Shorter/Longer Oral MDR-TB Regimen
H5Content
Management of QT Prolongation by Grade of Severity of ADR
H5Content
Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up
H5Content
Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment
H5Content
Drugs Not Included in Groups A - C and Rationale for Non-inclusion
H5Content
Rationale for Grouping of Anti-TB Drugs
H5Content
Management of DR-TB ADR: Gynecomastia
H5Content
Management of DR-TB ADR: Psychotic Symptoms
H5Content
Pagination
First page
« First
Previous page
‹‹
…
Page
49
Page
50
Page
51
Page
52
Current page
53
Page
54
Page
55
Page
56
Page
57
Next page
››
Last page
Last »
Subscribe to Final Review